Gifts
Awww...I have no gifts.
You can be the first to send me a gift!
Send me a gift now!
My Music
Guestbook
7/28/2009 7:19 PMhii
"Cangen is extremely pleased with the results thus far of this collaboration," said Chul So Moon, M.D., Ph.D., Chief Executive Officer and Chief Science Officer of Cangen Biotechnologies. "Together with our partners at DNP, we are poised to introduce the first blood test diagnostic for early stage lung cancer."
Cangen and DNP will begin the clinical trial phase in early 2009 with FDA submission of the test expected by 2011. "As we move forward with this new biotechnology, we are excited about the prospect of being able to offer earlier lung cancer detection with greater accuracy," said Cathy McDermott, RN, MPH, Vice President, Regulatory Affairs and Technical Development, Cangen Biotechnologies.
To accelerate the project, Cangen will receive a milestone payment as part of the Technical Collaboration Agreement with DNP initiated in March 2007, for its technical contribution to the collaboration. Further development of the product may lead to additional milestone payments to Cangen toward the funding of a Phase 3 trial in the United States.
According to the Centers for Disease Control (CDC), more people die annually from lung cancer than any other type of cancer. The National Cancer Institute estimates over 215,000 new cases and over 160,000 deaths from lung cancer (non-small cell and small cell combined) in the
Cangen and DNP will begin the clinical trial phase in early 2009 with FDA submission of the test expected by 2011. "As we move forward with this new biotechnology, we are excited about the prospect of being able to offer earlier lung cancer detection with greater accuracy," said Cathy McDermott, RN, MPH, Vice President, Regulatory Affairs and Technical Development, Cangen Biotechnologies.
To accelerate the project, Cangen will receive a milestone payment as part of the Technical Collaboration Agreement with DNP initiated in March 2007, for its technical contribution to the collaboration. Further development of the product may lead to additional milestone payments to Cangen toward the funding of a Phase 3 trial in the United States.
According to the Centers for Disease Control (CDC), more people die annually from lung cancer than any other type of cancer. The National Cancer Institute estimates over 215,000 new cases and over 160,000 deaths from lung cancer (non-small cell and small cell combined) in the
Thinking Of You Comments and Graphics![http://www.dazzlejunction.com/][IMG]http://i92.photobucket.com/albums/l23/dazzlejunction/0hz/greetings/hugs/hug_1.gif[/IMG][/URL](/link/http://www.dazzlejunction.com/][IMG]http://i92.photobucket.com/albums/l23/dazzlejunction/0hz/greetings/hugs/hug_1.gif[/IMG][/URL){kind=link}
12/23/2009 2:51 PMhi